N4 Pharma PLC (N4P) — Tangible Net Worth Ratio

Latest as of June 2025: 100.0%

N4 Pharma PLC (N4P) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (GBX0.00) from net assets (GBX1.77 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See N4P working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

100.0%
Tangible equity / total equity

Net Assets (Equity)

GBX1.77 Million
GBX

Intangible Assets

GBX0.00
Goodwill, patents, brand value

Total Assets

GBX1.85 Million
GBX

N4 Pharma PLC Tangible Net Worth Ratio (1985–2024)

This chart shows how N4 Pharma PLC's Tangible Net Worth Ratio has changed across 34 annual periods from 1985 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of GBX1.77 Million with intangible assets of GBX0.00 GBX. See operational self-sufficiency of N4 Pharma PLC to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for N4 Pharma PLC (1985–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for N4 Pharma PLC from 1985 to 2024, covering 34 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see N4P market cap.

Year Tangible NW Ratio Net Assets (GBX) Intangible Assets Total Assets Change (pp)
2024 100.0% GBX651.40K GBX0.00 GBX775.77K ▲ +0.0 pp
2023 100.0% GBX1.19 Million GBX0.00 GBX1.28 Million ▲ +0.0 pp
2022 100.0% GBX2.09 Million GBX0.00 GBX2.17 Million ▲ +0.0 pp
2021 100.0% GBX2.13 Million GBX0.00 GBX2.34 Million ▲ +0.0 pp
2020 100.0% GBX3.66 Million GBX0.00 GBX3.83 Million ▲ +0.0 pp
2019 100.0% GBX987.34K GBX0.00 GBX1.07 Million ▲ +0.0 pp
2018 100.0% GBX879.94K GBX0.00 GBX1.07 Million ▲ +0.0 pp
2017 100.0% GBX1.28 Million GBX0.00 GBX1.46 Million ▲ +0.0 pp
2016 100.0% GBX1.04 Million GBX0.00 GBX1.12 Million ▲ +0.0 pp
2015 100.0% GBX641.00K GBX0.00 GBX658.00K ▲ +0.0 pp
2014 100.0% GBX1.04 Million GBX0.00 GBX1.85 Million ▲ +39.9 pp
2013 60.1% GBX3.45 Million GBX1.38 Million GBX4.35 Million ▼ -4.5 pp
2012 64.5% GBX3.60 Million GBX1.28 Million GBX4.85 Million ▼ -1.2 pp
2011 65.8% GBX3.49 Million GBX1.19 Million GBX4.96 Million ▼ -0.2 pp
2010 66.0% GBX2.96 Million GBX1.01 Million GBX3.99 Million ▼ -9.8 pp
2009 75.8% GBX2.63 Million GBX636.00K GBX3.79 Million ▼ -6.1 pp
2008 81.9% GBX1.43 Million GBX259.00K GBX1.98 Million ▼ -17.6 pp
2007 99.5% GBX1.17 Million GBX6.00K GBX1.70 Million ▲ +0.3 pp
2006 99.2% GBX903.00K GBX7.00K GBX1.41 Million ▼ -0.8 pp
2005 100.0% GBX388.00K GBX0.00 GBX4.26 Million ▲ +0.0 pp
2004 100.0% GBX836.00K GBX0.00 GBX4.90 Million ▲ +14.8 pp
1997 85.2% GBX1.03 Million GBX152.00K GBX27.20 Million ▼ -7.1 pp
1996 92.4% GBX10.93 Million GBX832.00K GBX34.48 Million ▼ -3.6 pp
1995 96.0% GBX12.21 Million GBX493.00K GBX37.42 Million ▲ +95.0 pp
1994 0.9% GBX10.48 Million GBX10.38 Million GBX29.35 Million ▼ -10.7 pp
1993 11.6% GBX8.26 Million GBX7.30 Million GBX20.40 Million ▲ +51.6 pp
1992 -40.0% GBX7.03 Million GBX9.84 Million GBX25.25 Million ▼ -3.5 pp
1991 -36.5% GBX9.33 Million GBX12.73 Million GBX29.38 Million ▼ -92.0 pp
1990 55.5% GBX9.64 Million GBX4.29 Million GBX15.85 Million ▼ -44.5 pp
1989 100.0% GBX11.09 Million GBX0.00 GBX18.29 Million ▲ +0.0 pp
1988 100.0% GBX9.13 Million GBX0.00 GBX16.29 Million ▲ +0.0 pp
1987 100.0% GBX8.47 Million GBX0.00 GBX14.58 Million ▲ +0.0 pp
1986 100.0% GBX7.93 Million GBX0.00 GBX12.62 Million ▲ +0.0 pp
1985 100.0% GBX7.54 Million GBX0.00 GBX13.13 Million
pp = percentage points